SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Products > Clinical Study

AmealPeptide Overview & Studies

Published: 23-Jan-2013 | Format: PDF file | Document type: Clinical Study

AmealPeptide®: Clinically Proven to Maintain Blood Pressure Levels Already within Normal Range*
 
Maintaining blood pressure within healthy limits and promoting arterial flexibility are key strategies for enhancing cardiovascular health. AmealPeptide® is a clinically proven fermented milk protein that does both.* Supported by a dozen placebo-controlled human clinical trials, AmealPeptide® has been shown to maintain both systolic and diastolic blood pressure already within healthy limits and to encourage arterial flexibility.*
 
AmealPeptide® is produced through a proprietary fermentation and enzymatic process that releases two tripeptides, VPP and IPP. These tripeptides work by inhibiting an enzyme that constricts the blood vessels, thus promoting normal blood circulation.* AmealPeptide® has FDA-notified GRAS status.
 
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Supplier's Info Centre

Maypro